-
Ovarian Cancer
839
global
1
1.0
9
1.0
1.0
Clinical Case
0
1
Hematology-Oncology2023-03-26 20:00:00
Integrating maintenance therapy into treatment for patients with ovarian cancer
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Breast Cancer
840
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-03-26 20:00:00
Which of the guidelines for use of CDK 4/6 inhibitors do you use to guide treatment for patients with HR-positive/HER2-negative early breast cancer?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Antiretroviral Therapy for HIV Infection
3029660
global
1
0.5
9
0.5
2
0.5
0.5
Roundtable
0
1
Family Medicine/Primary Care2023-03-26 20:00:00
Can you help patients overcome barriers to pre-exposure prophylaxis (PrEP) for HIV prevention?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Ulcerative Colitis
564
global
1
0.75
9
0.75
0.75
Roundtable
0
1
Gastroenterology2023-03-23 20:00:00
Did you know that 75% to 90% of patients with ulcerative colitis (UC) report bowel urgency and that up to 50% of patients with UC experience urgency at least once a day?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Advanced and Metastatic Breast Cancer
846
global
1
0.25
9
0.25
0.25
Commentary
0
1
Hematology-Oncology2023-03-22 20:00:00
Aromatase inhibitors (AIs), selective estrogen receptor modulators (SERMs), and selective estrogen receptor degraders (SERDs). How do they work and when should they be added to the treatment of metastatic hormone receptor (HR)-positive breast cancer?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Infertility Female
3032465
global
1
0.25
9
0.25
0.25
Roundtable
0
1
Ob/Gyn & Women's Health2023-03-20 20:00:00
Do you know how to assess and monitor your patients' fertility?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Ovarian Cancer
839
global
1
1.0
9
1.0
1.0
Clinical Case
0
1
Hematology-Oncology2023-03-26 20:00:00
Integrating maintenance therapy into treatment for patients with ovarian cancer
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Breast Cancer
840
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-03-26 20:00:00
Which of the guidelines for use of CDK 4/6 inhibitors do you use to guide treatment for patients with HR-positive/HER2-negative early breast cancer?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Antiretroviral Therapy for HIV Infection
3029660
global
1
0.5
9
0.5
2
0.5
0.5
Roundtable
0
1
Family Medicine/Primary Care2023-03-26 20:00:00
Can you help patients overcome barriers to pre-exposure prophylaxis (PrEP) for HIV prevention?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Ulcerative Colitis
564
global
1
0.75
9
0.75
0.75
Roundtable
0
1
Gastroenterology2023-03-23 20:00:00
Did you know that 75% to 90% of patients with ulcerative colitis (UC) report bowel urgency and that up to 50% of patients with UC experience urgency at least once a day?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Advanced and Metastatic Breast Cancer
846
global
1
0.25
9
0.25
0.25
Commentary
0
1
Hematology-Oncology2023-03-22 20:00:00
Aromatase inhibitors (AIs), selective estrogen receptor modulators (SERMs), and selective estrogen receptor degraders (SERDs). How do they work and when should they be added to the treatment of metastatic hormone receptor (HR)-positive breast cancer?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Infertility Female
3032465
global
1
0.25
9
0.25
0.25
Roundtable
0
1
Ob/Gyn & Women's Health2023-03-20 20:00:00
Do you know how to assess and monitor your patients' fertility?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Breast Cancer
840
global
1
1.0
9
1.0
1.0
Clinical Case
0
1
Hematology-Oncology2023-03-20 20:00:00
Do you know the best approaches for identifying and managing high-risk, hormone receptor positive early breast cancer?
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Infertility Female
3032465
global
1
0.25
2
0.25
3
0.25
8
0.25
0.25
Clinical Brief
0
1
Ob/Gyn & Women's Health2023-03-16 20:00:00
School-age developmental/educational outcomes for children conceived by IVF should reassure current and prospective parents and clinicians.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Advanced and Metastatic Breast Cancer
846
us
1
1.0
1.0
Clinical Case
0
1
Pathology & Lab Medicine2023-03-13 20:00:00
Are you up to date with the latest guidance and best practices in breast cancer human epidermal growth factor receptor 2 (HER2) testing? Learn more here!
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Pregnancy
3032471
global
1
0.75
9
0.75
2
0.75
3
0.75
0.75
Roundtable
0
1
Ob/Gyn & Women's Health2023-02-23 19:00:00
Did you know continuous glucose monitoring (CGM) use during pregnancy can have benefits for mother and baby?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Pregnancy
3032471
global
1
0.25
9
0.25
2
0.25
3
0.25
8
0.25
0.25
Clinical Brief
0
1
Hematology-Oncology2023-02-23 19:00:00
A recent cohort study discusses outcomes in children exposed to maternal cancer in utero, with or without chemotherapy.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Pregnancy
3032471
global
1
0.25
9
0.25
2
0.25
8
0.25
0.25
Clinical Brief
0
1
Ob/Gyn & Women's Health2023-02-16 19:00:00
A new study provides insight on women with disability and their access to postdelivery breastfeeding support.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Pregnancy
3032471
global
1
0.25
2
0.25
3
0.25
8
0.25
0.25
Clinical Brief
0
1
Ob/Gyn & Women's Health2023-02-16 19:00:00
This study highlights inequities that must be overcome in order to support a diet that optimizes maternal and newborn outcomes.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Headache
1457
global
1
0.25
9
0.25
2
0.25
3
0.25
8
0.25
0.25
Clinical Brief
0
1
Neurology & Neurosurgery2023-02-16 19:00:00
Significant sex differences in cluster headache should be considered at time of diagnosis and when choosing treatment options.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
ADHD
3031959
global
1
0.25
9
0.25
2
0.25
3
0.25
8
0.25
0.25
Clinical Brief
0
1
Diabetes & Endocrinology2023-02-02 19:00:00
A cohort study highlights the need to prioritize healthy weight gain during pregnancy, but larger studies in broader populations are needed.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Pregnancy
3032471
global
1
0.25
9
0.25
2
0.25
8
0.25
0.25
Clinical Brief
0
1
Ob/Gyn & Women's Health2023-02-02 19:00:00
Are better postpartum hemorrhage diagnosis and national quality efforts able to explain any changes in transfusion and hysterectomy rates?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Type 1 Diabetes Mellitus
1068
global
1
0.5
9
0.5
2
0.5
3
0.5
0.5
Roundtable
0
1
Diabetes & Endocrinology2023-01-29 19:00:00
Are you up to speed on the latest AID technology and how to use it in your practice? Our experts discuss the new 2022 consensus recommendations.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Breast Cancer
840
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-01-29 19:00:00
Will the newly reported monarchE data change your clinical practice for patients with HR+/HER- early breast cancer?
0.5ABIM MOC
0.5CME/CE
30MIN
Save